Legal & General Group PLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$17.63 - $21.74 $16,343 - $20,152	927 Added 3.7%	25,995 $512,000
Q4 2023 Feb 15, 2024	BUY	$14.37 - $19.07 $13,565 - $18,002	944 Added 3.91%	25,068 $439,000
Q3 2023 Nov 14, 2023	BUY	$13.62 - $20.2 $749 - $1,111	55 Added 0.23%	24,124 $419,000
Q2 2023 Aug 14, 2023	BUY	$10.44 - $16.48 $121,563 - $191,893	11,644 Added 93.71%	24,069 $338,000
Q1 2023 May 15, 2023	BUY	$10.7 - $15.79 $7,629 - $11,258	713 Added 6.09%	12,425 $133,000
Q4 2022 Feb 14, 2023	BUY	$11.42 - $17.05 $9,707 - $14,492	850 Added 7.83%	11,712 $175,000
Q3 2022 Nov 14, 2022	BUY	$9.76 - $13.41 $1,444 - $1,984	148 Added 1.38%	10,862 $139,000
Q2 2022 Aug 22, 2022	BUY	$7.6 - $11.41 $16,431 - $24,668	2,162 Added 25.28%	10,714 $103,000
Q3 2021 Nov 15, 2021	BUY	$11.39 - $16.23 $53,897 - $76,800	4,732 Added 123.87%	8,552 $97,000
Q2 2021 Aug 12, 2021	SELL	$13.22 - $19.09 $7,945 - $11,473	-601 Reduced 13.59%	3,820 $53,000
Q1 2021 May 17, 2021	BUY	$16.68 - $23.97 $2,168 - $3,116	130 Added 3.03%	4,421 $82,000
Q3 2020 Nov 13, 2020	BUY	$15.21 - $25.53 $441 - $740	29 Added 0.68%	4,291 $66,000
Q2 2020 Aug 14, 2020	BUY	$15.08 - $26.0 $29,933 - $51,610	1,985 Added 87.18%	4,262 $108,000
Q1 2020 May 14, 2020	SELL	$11.0 - $19.76 $8,965 - $16,104	-815 Reduced 26.36%	2,277 $29,000
Q4 2019 Feb 13, 2020	BUY	$5.24 - $12.96 $2,813 - $6,959	537 Added 21.02%	3,092 $34,000
Q2 2019 Aug 14, 2019	BUY	$13.2 - $20.39 $7,458 - $11,520	565 Added 28.39%	2,555 $35,000
Q1 2019 May 15, 2019	BUY	$15.93 - $26.59 $16,089 - $26,855	1,010 Added 103.06%	1,990 $36,000
Q3 2018 Nov 20, 2018	BUY	$13.23 - $30.93 $12,965 - $30,311	980 New	980 $25,000

Others Institutions Holding KNSA

# of Institutions

Shares Held

1.95M

Call Options Held

Put Options Held

Pictet Asset Management Sa Geneva 73, V8

1.52M
Shares

$30.2 Million
0.03% of portfolio
Spearhead Capital Advisors, LLC Wellington, FL

203K
Shares

$4.04 Million
2.82% of portfolio
Harbor Capital Advisors, Inc.

98.1K
Shares

$1.95 Million
0.08% of portfolio
Putnam Investments LLC Boston, MA

39.5K
Shares

$786,955
0.0% of portfolio
Birchview Capital, LP Burlington, VT

30K
Shares

$597,900
0.69% of portfolio

View Full List

About Kiniksa Pharmaceuticals, Ltd.

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $687M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

More about KNSA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account